NASDAQ:NVNO
enVVeno Medical Corp
enVVeno Medical Corp reported net income of −$19.5M in fiscal 2025. Free cash flow was −$15.6M, and the diluted share count rose 20.2%.Summary generated from enVVeno Medical Corp's SEC filings. Latest annual report filed Mar 26, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−56.2%
Debt / equityn/a
Free cash flow−$15.6M
FCF marginn/a
Share count change+20.2%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Operating income | −17 | −25 | −25 | −24 | −21 |
| Net income | −17 | −25 | −24 | −22 | −19 |
| Free cash flow | −12 | −16 | −19 | −17 | −16 |
Recent filings
- 4Insider transaction report
Sep 14, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 30, 2026 - 8-KRegulation FD disclosure
Jul 14, 2026 - 4Insider transaction report
Jun 12, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 6, 2026 - 8-KResults of operations and financial condition
Apr 29, 2026 - 10-KAnnual report for the fiscal year ended Dec 31, 2025
Mar 26, 2026 - 8-KResults of operations and financial condition
Feb 4, 2026